Dr. Reddy's Laboratories, an integrated global pharmaceutical company, has introduced Metoprolol Succinate extended-release (ER) tablets of 25mg, 50mg, 100mg and 200mg strengths in the US.
The bioequivalent generic version of AstraZeneca's Toprol-XL (Metoprolol Succinate) tablets, approved by the FDA, is indicated to treat high blood pressure.
The Toprol-XL brand and generic had US sales for the most recent twelve months ending June 2012 were approximately $1.13bn according to IMS Health.
Dr. Reddy's is making Metoprolol Succinate ER tablets in 25mg, 50mg, 100mg and 200mg strengths available in bottle counts of 100 and 500.
Dr. Reddy's offers a portfolio of products and services including APIs, custom pharmaceutical services, generics, biosimilars, differentiated formulations and NCEs.
